This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Apr;31(2):185-187.

doi: 10.1111/joic.12505.

Editorial: Why should we use bivalirudin today?

Carl D Reimers¹, Afnan Tariq¹, Varinder P Singh¹

Affiliations

PMID: 29644753
DOI: 10.1111/joic.12505

Free article

Editorial

Editorial: Why should we use bivalirudin today?

Carl D Reimers et al. J Interv Cardiol. 2018 Apr.

Free article

. 2018 Apr;31(2):185-187.

doi: 10.1111/joic.12505.

Authors

Carl D Reimers¹, Afnan Tariq¹, Varinder P Singh¹

Affiliation

¹ Zucker School of Medicine at Hofstra Northwell, Northwell Health, Lenox Hill Hospital, New York, New York.

PMID: 29644753
DOI: 10.1111/joic.12505

No abstract available

PubMed Disclaimer

Comment on

The impact of unfractionated heparin or bivalirudin on patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Lima FV, Gruberg L, Aslam U, Ramgadoo M, Clase K, Trevisan A, Jeremias A. Lima FV, et al. J Interv Cardiol. 2018 Apr;31(2):177-184. doi: 10.1111/joic.12462. Epub 2017 Dec 4. J Interv Cardiol. 2018. PMID: 29205487 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations